Pragmatic Trial of Video Education in Nursing Homes
- Conditions
- Alzheimer DiseasePulmonary Disease, Chronic ObstructiveHeart FailureDementia
- Interventions
- Behavioral: ACP Video Program
- Registration Number
- NCT02612688
- Lead Sponsor
- Brown University
- Brief Summary
This is a pragmatic cluster-randomized control trial (RCT) of an Advance Care Planning (ACP) Video Program for nursing home (NH) patients ≥ 65 years old who are cared for in 360 NH facilities (intervention arm n=119; control arm n=241) within two NH health care systems: Genesis HealthCare and PruittHealth. The intervention NH facilities will implement the ACP Video Program, while the control NH facilities will follow their usual ACP procedures. The trial will evaluate the effectiveness of the ACP Video Program by comparing hospitalizations, advance directives, and hospice use in the intervention vs. control NHs.
- Detailed Description
Nursing homes are complex health care systems that serve increasingly sick patients who have advanced comorbid conditions. NHs are often charged with guiding patients through decisions about the direction of their treatment. Patients at NHs commonly get aggressive care that may be inconsistent with their preferences and of little clinical benefit. Identifying effective approaches that NHs can use to better promote goal-directed care and optimize resources is a research, public health, and clinical priority.
Advance care planning is the most consistent modifiable factor associated with better palliative care outcomes. Traditional ACP relies on verbal descriptions of hypothetical health states and treatments. This approach is limited because complex scenarios are difficult to envision, counseling is inconsistent, and verbal explanations are hindered by literacy and language barriers.
To address these shortcomings, the PROVEN project has developed video-assisted ACP decision-support tools that have shown efficacy in small randomized controlled trials. While several large health care systems have begun to adopt the videos, efforts have not rigorously evaluated outcomes-a critical step prior to widespread implementation.
The goal of PROVEN is to conduct a pragmatic cluster-randomized trial to evaluate the effectiveness of the ACP Video Program in the NH setting by partnering with 2 large health care systems that operate 456 nursing homes nationwide. This work has the potential to improve the care provided to millions of older Americans in nursing homes and enable future pragmatic trials in this setting.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 197692
- Facilities are within Genesis HealthCare or PruittHealth health care systems
- Facilities have facility identifiers that indicate that they are Medicare/Medicaid-certified nursing facilities in the U.S.
- Facilities serve both short and long-stay patients
- Facilities have >50 beds
- Facilities have an electronic medical records system
- Facilities had at least 20 admissions and 20 annual Minimum Data Set (MDS) assessments (regardless of whether they were discharged alive) in 2013
- Facilities excluded per corporate leaders in health care system because of recent turnover in NH administrator or Director of Nursing
- Facilities excluded per corporate leaders in health care system because of recent bad state or federal quality assurance survey (e.g. restriction on admissions, levied large civil monetary penalty, etc.)
- Facilities excluded per corporate leaders in health care system because of current new initiatives/competing demands
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description ACP Video Program ACP Video Program Facility asked to implement ACP Video Program
- Primary Outcome Measures
Name Time Method Hospital Transfer Rate in Target Cohort 12-month observation period Number of hospital transfers (number of transfers/person-days alive) over a 12-month observation period among Medicare fee-for-service long-stay residents (in a NH \>=90 days) who are \>=65 years old and who have EITHER advanced dementia or advanced congestive heart failure/chronic obstructive lung disease
- Secondary Outcome Measures
Name Time Method Hospital Transfer Rate Among Long-stay Residents Without Advanced Illness 12-month observation period Number of hospital transfers (number of transfers/person-days alive) over a 12-month observation period among Medicare fee-for-service long-stay residents (in a NH \>=90 days) who are \>=65 years old and who have NEITHER advanced dementia NOR advanced congestive heart failure/chronic obstructive lung disease
Proportion of Long-stay Residents Without Advanced Illness With Last Observed Advance Directive Status 12-month observation period Proportion of long-stay residents (in a NH \>=90 days) who are \>=65 years old and who do have NEITHER advanced dementia NOR advanced congestive heart failure/chronic obstructive lung disease whose last observed advance directive status during their 12-month observation period was: Full Code, Do Not Resuscitate (NOT Do Not Hospitalize), or Do Not Hospitalize. A resident whose last observed status was both Do Not Resuscitate and Do Not Hospitalize is categorized as Do Not Hospitalize only. Analyses will be limited to Genesis HealthCare facilities in which \>75% of residents have any advance directive because the remaining Genesis HealthCare and PruittHealth facilities do not have reliable sources for these data.
Proportion of Short-stay Residents Without Advanced Illness Receiving Any Burdensome Treatment 100-day observation period Proportion of short-stay residents (in a NH \<90 days) who are \>=65 years old and who have NEITHER advanced dementia NOR advanced congestive heart failure/chronic obstructive lung disease who receive any burdensome treatment (new feeding tube insertions, parenteral therapy, intubation, ICU care) during a 100-day observation period
Proportion of Long-stay Residents Without Advanced Illness With Any Hospice Enrollment 12-month observation period Proportion of long-stay residents (in a NH \>=90 days) who are \>=65 years old and who have NEITHER advanced dementia NOR advanced congestive heart failure/chronic obstructive lung disease with any hospice enrollment during a 12-month observation period
Proportion of Short-stay Residents Without Advanced Illness With Any Hospice Enrollment 100-day observation period Proportion of short-stay residents (in a NH \<90 days) who are \>=65 years old and who have NEITHER advanced dementia NOR advanced congestive heart failure/chronic obstructive lung disease with any hospice enrollment during a 100-day observation period
Proportion of Short-stay Residents With Advanced Illness That Has Medicare ACP Billing Codes 100-day observation period Proportion of short-stay residents (in a NH \<90 days) who are \>=65 years old and who have EITHER advanced dementia OR advanced congestive heart failure/chronic obstructive lung disease who have any Medicare ACP billing code during their 100-day observation period
Proportion of Short-stay Residents Without Advanced Illness That Has Medicare ACP Billing Codes 100-day observation period Proportion of short-stay residents (in a NH \<90 days) who are \>=65 years old and who have NEITHER advanced dementia NOR advanced congestive heart failure/chronic obstructive lung disease who have any Medicare ACP billing code during their 100-day observation period
Hospital Transfer Rate Among Short-stay Residents With Advanced Illness 100-day observation period Number of hospital transfers (number of transfers/person-days alive) over a 100-day observation period among Medicare fee-for-service short-stay residents (in a NH \<90 days) who are \>=65 years old and who have EITHER advanced dementia OR advanced congestive heart failure/chronic obstructive lung disease
Proportion of Short-stay Residents With Advanced Illness With Last Observed Advance Directive Status 100-day observation period Proportion of short-stay residents (in a NH \<90 days) who are \>=65 years old and who have EITHER advanced dementia OR advanced congestive heart failure/chronic obstructive lung disease whose last observed advance directive status during their 100-day observation period was: Full Code, Do Not Resuscitate (NOT Do Not Hospitalize), or Do Not Hospitalize. A resident whose last observed status was both Do Not Resuscitate and Do Not Hospitalize is categorized as Do Not Hospitalize only. Analyses will be limited to Genesis HealthCare facilities in which \>75% of residents have any advance directive because the remaining Genesis HealthCare and PruittHealth facilities do not have reliable sources for these data.
Proportion of Long-stay Residents Without Advanced Illness Receiving Any Burdensome Treatment 12-month observation period Proportion of long-stay residents (in a NH \>=90 days) who are \>=65 years old and who have NEITHER advanced dementia NOR advanced congestive heart failure/chronic obstructive lung disease who receive any burdensome treatment (new feeding tube insertions, parenteral therapy, intubation, ICU care) during a 12-month observation period
Proportion of Short-stay Residents Without Advanced Illness With Last Observed Advance Directive Status 100-day observation period Proportion of short-stay residents (in a NH \<90 days) who are \>=65 years old and who have NEITHER advanced dementia NOR advanced congestive heart failure/chronic obstructive lung disease whose last observed advance directive status during their 100-day observation period was: Full Code, Do Not Resuscitate (NOT Do Not Hospitalize), or Do Not Hospitalize. A resident whose last observed status was both Do Not Resuscitate and Do Not Hospitalize is categorized as Do Not Hospitalize only. Analyses will be limited to Genesis HealthCare facilities in which \>75% of residents have any advance directive because the remaining Genesis HealthCare and PruittHealth facilities do not have reliable sources for these data.
Proportion of Short-stay Residents With Advanced Illness With Any Hospice Enrollment 100-day observation period Proportion of short-stay residents (in a NH \<90 days) who are \>=65 years old and who have EITHER advanced dementia OR advanced congestive heart failure/chronic obstructive lung disease with any hospice enrollment during a 100-day observation period
Hospital Transfer Rate Among Short-stay Residents Without Advanced Illness 100-day observation period Number of hospital transfers (number of transfers/person-days alive) over a 100-day observation period among Medicare fee-for-service short-stay residents (in a NH \<90 days) who are \>=65 years old and who have NEITHER advanced dementia NOR advanced congestive heart failure/chronic obstructive lung disease
Proportion of Target Cohort With Last Observed Advance Directive Status 12-month observation period Proportion of long-stay residents (in a NH \>=90 days) who are \>=65 years old and who have EITHER advanced dementia OR advanced congestive heart failure/chronic obstructive lung disease whose last observed advance directive status during their 12-month observation period was: Full Code, Do Not Resuscitate (NOT Do Not Hospitalize), or Do Not Hospitalize. A resident whose last observed status was both Do Not Resuscitate and Do Not Hospitalize is categorized as Do Not Hospitalize only. Analyses will be limited to Genesis HealthCare facilities in which \>75% of residents have any advance directive because the remaining Genesis HealthCare and PruittHealth facilities do not have reliable sources for these data.
Proportion of Target Cohort Receiving Any Burdensome Treatment 12-month observation period Proportion of long-stay residents (in a NH \>=90 days) who are \>=65 years old and who have EITHER advanced dementia OR advanced congestive heart failure/chronic obstructive lung disease who receive any burdensome treatment (new feeding tube insertions, parenteral therapy, intubation, ICU care) during a 12-month observation period
Proportion of Short-stay Residents With Advanced Illness Receiving Any Burdensome Treatment 100-day observation period Proportion of short-stay residents (in a NH \<90 days) who are \>=65 years old and who have EITHER advanced dementia OR advanced congestive heart failure/chronic obstructive lung disease who receive any burdensome treatment (new feeding tube insertions, parenteral therapy, intubation, ICU care) during a 100-day observation period among
Proportion of Target Cohort With Any Hospice Enrollment 12-month observation period Proportion of long-stay residents (in a NH \>=90 days) who are \>=65 years old and who have EITHER advanced dementia OR advanced congestive heart failure/chronic obstructive lung disease with any hospice enrollment during a 12-month observation period
Proportion of Target Cohort That Has Medicare ACP Billing Codes 12-month observation period Proportion of long-stay residents (in a NH \>=90 days) who are \>=65 years old and who have EITHER advanced dementia OR advanced congestive heart failure/chronic obstructive lung disease who have any Medicare ACP billing code during their 12-month observation period
Proportion of Long-stay Residents Without Advanced Illness That Has Medicare ACP Billing Codes 12-month observation period Proportion of long-stay residents (in a NH \>=90 days) who are \>=65 years old and who have NEITHER advanced dementia NOR advanced congestive heart failure/chronic obstructive lung disease who have any Medicare ACP billing code during their 12-month observation period
Trial Locations
- Locations (2)
PruittHealth
🇺🇸Norcross, Georgia, United States
Genesis HealthCare
🇺🇸Kennett Square, Pennsylvania, United States